iTag™ MHC Tetramers

Company
Beckman Coulter, Inc.
Use
Used for the ex vivo quantification of cellular immune response
Features
MHC Tetramer technology has been used to accurately monitor CD8+ T cell responses (viruses, parasitic infections, cancers)
NIH Contribution
Sequenced various melanoma peptides
HHS Institute/Agency
NCI
Inventor(s)
Y. Kawakami, S. Rosenberg
Year
2001
Tech Cat
Research Reagent

Request More Info

L-262-2001